476
Jochen Weiss et al.
emulsions containing a mixture of solid and liquid droplets. J. Colloid Interface Sci., 160(2), 293–297. McClements, D. J., & Dungan, S. R. (1997). Effect of colloidal interactions on the rate of interdroplet heterogeneous nucleation in oil-in-water emulsions. J. Colloid Interface Sci., 186(1), 17–28. Mehnert, W., & Mader, K. (2001). Solid lipid nanoparticles: Production, characterization and applications. Adv. Drug Delivery Rev., 47(2–3), 165–196. Menon, K. V., & Garg, S. R. (2001). Inhibitory effect of clove oil on Listeria monocytogenes in meat and cheese. J. Food Microbiol., 18, 647–650. Miller, A. M., & Raney, K. H. (1993). Solubilization & emulsification: Mechanisms of detergency. Colloids Surfaces A, 74, 169–215. Moleyar, V., & Narasimham, P. (1992). Antimicrobial activity of essential oil components. Intern. J. Food Microbiol., 16, 337–342. Moreau, L., Kim, H. J., Decker, E. A., & McClements, D. J. (2003). Production and characterization of oil-in-water emulsions containing droplets stabilized by betalactoglobulin-pectin membranes. J. Agricultural Food Chem., 51(22), 6612–6617. Mu¨ller, R. H., Freitas, C., zur Mu¨hlen, A., & Mehnert, W. (1996a). Solid lipid nanoparticles (SLN) for controlled drug delivery. Euro. J. Pharmaceutical Sci., 4(Supplement 1), S75. Mu¨ller, R. H., Maassen, S., Weyhers, H., & Mehnert, W. (1996b). Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407. J. Drug Target., 4(3), 161–170. Mu¨ller, R. H., Maassen, S., Schwarz, C., & Mehnert, W. (1997). Solid lipid nanoparticles (SLN) as potential carrier for human use: interaction with human granulocytes. J. Control. Release, 47(3), 261–269. Mu¨ller, R. H., Jacobs, C., & Kayser, O. (2001). Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv. Drug Deliv. Rev., 47(1), 3–19. Mu¨ller, R. H., Radtke, M., & Wissing, S. A. (2002). Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev., 54, S131–S155. Mulligan, C. N., Yong, R. N., & Gibbs, B. F. (2001). Surfactant-enhanced remediation of contaminated soil: a review. Engineer. Geol., 60, 371–380. Nishikido, N. (1993). Thermodynamic models for mixed micellar systems. In K. Ogino, & M. and Abe (Eds.), Mixed Surfactant Systems. New York: Marcel Dekker. NNI (National Nanotechnology Initiative). (2008). About the NNI. Accessed website 04/08. (). http://www.nano.gov/. Ogawa, S., Decker, E. A., & McClements, D. J. (2003a). Influence of environmental conditions on the stability of oil in water emulsions containing droplets stabilized by lecithin-chitosan membranes. J. Agricultural Food Chem., 51(18), 5522–5527. Ogawa, S., Decker, E. A., & McClements, D. J. (2003b). Production and characterization of O/W emulsions containing cationic droplets stabilized by lecithin-chitosan membranes. J. Agricultural Food Chem., 51(9), 2806–2812. Oka, S. (1964). Mechanism of antimicrobial effect of various food preservatives. Intern. Symposium Food Microbiol., 4, 3–16. Palanuwech, J., & Coupland, J. N. (2003). Effect of surfactant type on the stability of oil-in-water emulsions to dispersed phase crystallization. Colloids and Surfaces A – Physicochemical and Engineering Aspects, 223(1–3), 251–262. Paster, N., Juven, B. J., Shaaya, E., Menasherov, M., Nitzan, R., Weisslowicz, H., & Ravid, U. (1990). Inhibitory effect of oregano and thyme essential oils on moulds and foodborne bacteria. Lett. Appl. Microbiol., 11, 33–37. Peracchia, M. T. (2003). Stealth nanoparticles for intravenous administration. Stp Pharma Sci., 13(3), 155–161.